KTTA
NASDAQ
$0.45
Pasithea Therapeutics Corp (KTTA)
Pasithea Therapeutics Corp. The company is headquartered in Miami Beach, Florida.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $3 (+559.63%)
Market Cap
$12M
P/B Ratio
0.29
Beta (5Y)
-0.11
Price Chart
Valuation
Market Cap$12M
P/S42.15
P/B0.29
Profitability
Gross Profit (TTM)-$2.21K
EBITDA-$20M
EPS-$1.46
Growth & Risk
Beta (5Y)-0.11
Sharpe Ratio0.30